News-Medical.Net November 11, 2024
Hebrew University of Jerusalem

A new study highlights the link between inflammation and depression, challenging traditional neurotransmitter-focused theories. An examination of decades of research suggests that immune system imbalances may trigger and sustain depressive symptoms, particularly in high-risk groups. This research paves the way for personalized treatments targeting inflammation, offering new hope for those unresponsive to conventional therapies.

Depression, recognized as the leading cause of disability worldwide, affects nearly one in six people over their lifetimes. Despite decades of research, much remains unknown about the biological mechanisms underlying this debilitating condition. Professor Raz Yirmiya, a pioneering researcher in the field of inflammation and depression from the Department of Psychology at the Hebrew University of Jerusalem, has recently published a comprehensive review in Brain, Behavior,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mental Health, Provider, Survey / Study, Trends
10 Clinical Pearls for Treating Mood Disorders
Rural Realities: Resilience and Revelations From a Year in Psychiatry
Employers sue to block mental health parity rule: 5 notes
2025 Top-Rated Behavioral Health Technology Vendors Announced: Black Book Research Recognizes the Best in Client Satisfaction and Innovation
The 2025 Black Book of Behavioral Health IT Released: A Competitive Intelligence Report

Share This Article